About: http://data.cimple.eu/news-article/1dff8250c1804019ed51fd1b7ed31298a25743737a99128043dedd53

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/1dff8250c1804019ed51fd1b7ed31298a25743737a99128043dedd53 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The prestigious Lancet medical journal said it is bolstering its scientific review process after being forced to retract a study into the effects of an anti-arthritis drug on Covid-19 patients. The research, released in May, prompted the World Health Organization to pause its trials of hydroxychloroquine after the results suggested it had no positive effects on hospitalised individuals and may in fact increase the likelihood of death. The study also whipped up fresh controversy over hydroxychloroquine, which has been endorsed by public figures -- including US President Donald Trump -- despite concerns over side effects and a lack of evidence that it is effective. The paper in question was retracted after a group of experts raised "both methodological and data integrity concerns" about it. These included a lack of information about the countries and hospitals that contributed to the data provided by Chicago-based healthcare data analytics firm Surgisphere. In a comment piece published late Thursday, The Lancet said the retraction had pushed it "to examine... peer-review processes to identify ways of further reducing risks of research and publication misconduct". Peer-reviewed research is checked by a collection of other experts before publication. The Lancet said it was introducing new review measures including ensuring at least one reviewer being knowledgeable on the area of research in question and expanded data sharing. "As trusted sources of information, the Lancet journals are committed to ensuring that our editorial processes will continue to be as robust as possible," it said. jc/pg/pvh
schema:headline	Lancet boosts review process after Covid study retraction
schema:mentions	Data integrity Data analysis The Lancet Hydroxychloroquine World Health Organization Coronavirus disease President of the United States Donald Trump Coronavirus disease 2019 Scholarly peer review Medical literature Data sharing PVH (company)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-09-18 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	90 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	suppressed cures conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software